ArticleActa pharmaceutica Sinica. B2024

A combined nanotherapeutic approach targeting farnesoid X receptor, ferroptosis, and fibrosis for nonalcoholic steatohepatitis treatment.

Jiangtao Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.